Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzenstein

Showing results (831-840 of 874) with videos related to

Pageof 88
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2013
Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253S Swindells, L Komarow, S Tripathy, et al.
Annals of Internal Medicine|February 16, 2011
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1Eric S Daar, Camlin Tierney, Margaret A Fischl, et al.
The Journal of Infectious Diseases|September 16, 2011
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final resultsPaul E Sax, Camlin Tierney, Ann C Collier, et al.
Antiviral Therapy|June 10, 2000
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis planV DeGruttola, L Dix, R D'Aquila, et al.
Neurology|October 10, 2001
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathyG Schifitto, C Yiannoutsos, D M Simpson, et al.
The New England Journal of Medicine|December 3, 2009
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapyPaul E Sax, Camlin Tierney, Ann C Collier, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2024
Education, employment, and income among people living with cystic fibrosis across three decades - A matched cohort study using Danish health registriesCamilla Bjørn Jensen, Kristoffer Jarlov Jensen, Tacjana Pressler, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern AfricaClive M Gray, Carolyn Williamson, Helba Bredell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern AfricaAgatha M Masemola, Tumelo N Mashishi, Greg Khoury, et al.
The Lancet. Oncology|April 13, 2019
Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trialHoward M Katzenstein, Max R Langham, Marcio H Malogolowkin, et al.
Pageof 88

Showing results (831-840 of 874) with videos related to

Sort By:
Pageof 88
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2013
Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253S Swindells, L Komarow, S Tripathy, et al.
Annals of Internal Medicine|February 16, 2011
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1Eric S Daar, Camlin Tierney, Margaret A Fischl, et al.
The Journal of Infectious Diseases|September 16, 2011
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final resultsPaul E Sax, Camlin Tierney, Ann C Collier, et al.
Antiviral Therapy|June 10, 2000
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis planV DeGruttola, L Dix, R D'Aquila, et al.
Neurology|October 10, 2001
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathyG Schifitto, C Yiannoutsos, D M Simpson, et al.
The New England Journal of Medicine|December 3, 2009
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapyPaul E Sax, Camlin Tierney, Ann C Collier, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2024
Education, employment, and income among people living with cystic fibrosis across three decades - A matched cohort study using Danish health registriesCamilla Bjørn Jensen, Kristoffer Jarlov Jensen, Tacjana Pressler, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern AfricaClive M Gray, Carolyn Williamson, Helba Bredell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern AfricaAgatha M Masemola, Tumelo N Mashishi, Greg Khoury, et al.
The Lancet. Oncology|April 13, 2019
Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trialHoward M Katzenstein, Max R Langham, Marcio H Malogolowkin, et al.
Pageof 88